0 XP   0   0   0

Alliance Pharma plc
Buy, Hold or Sell?

I guess you are interested in Alliance Pharma plc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse Alliance Pharma plc

Let's start. I'm going to help you getting a better view of Alliance Pharma plc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Alliance Pharma plc even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Alliance Pharma plc is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Alliance Pharma plc. The closing price on 2022-10-03 was p57.30 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Alliance Pharma plc Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is inefficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is just able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of Alliance Pharma plc.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Alliance Pharma plc earns for each 1 of revenue.

  • Above 10% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers-Specialty & Generic industry mean.
  • A Net Profit Margin of 0.0% means that 0.00 for each 1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Alliance Pharma plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y11.9%-11.9%
5Y11.9%10Y16.1%-4.1%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.7%-0.7%
TTM-1.0%-1.0%
YOY-1.7%-1.7%
5Y11.9%0.6%+11.3%
10Y16.1%1.2%+14.9%
1.1.2. Return on Assets

Shows how efficient Alliance Pharma plc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.4% Return on Assets means that Alliance Pharma plc generated 0.00 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Alliance Pharma plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.4%-0.4%
TTM0.4%YOY0.5%-0.1%
TTM0.4%5Y1.1%-0.7%
5Y1.1%10Y1.8%-0.6%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.2%-0.2%
TTM0.4%0.2%+0.2%
YOY0.5%0.1%+0.4%
5Y1.1%-0.1%+1.2%
10Y1.8%0.2%+1.6%
1.1.3. Return on Equity

Shows how efficient Alliance Pharma plc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers-Specialty & Generic industry mean.
  • 0.0% Return on Equity means the company generated 0.00 for each 1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Alliance Pharma plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.7%-0.7%
TTM0.7%YOY0.9%-0.2%
TTM0.7%5Y1.9%-1.1%
5Y1.9%10Y1.1%+0.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.8%-0.8%
TTM0.7%0.6%+0.1%
YOY0.9%0.6%+0.3%
5Y1.9%0.1%+1.8%
10Y1.1%0.5%+0.6%

1.2. Operating Efficiency of Alliance Pharma plc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Alliance Pharma plc is operating .

  • Measures how much profit Alliance Pharma plc makes for each 1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Alliance Pharma plc to the Drug Manufacturers-Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated 0.00  for each 1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Alliance Pharma plc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y14.3%-14.3%
5Y14.3%10Y21.1%-6.8%
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.5%-3.5%
TTM-2.3%-2.3%
YOY-3.9%-3.9%
5Y14.3%3.5%+10.8%
10Y21.1%1.9%+19.2%
1.2.2. Operating Ratio

Measures how efficient Alliance Pharma plc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are 0.00 for each 1 in net sales.

Let's take a look of the Operating Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.492-0.492
5Y0.49210Y0.627-0.134
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.480-1.480
TTM-1.435-1.435
YOY-1.383-1.383
5Y0.4921.363-0.871
10Y0.6271.160-0.533

1.3. Liquidity of Alliance Pharma plc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Current Ratio of 2.00 means the company has 2.00 in assets for each 1 in short-term debts.

Let's take a look of the Current Ratio trends of Alliance Pharma plc:

  • The MRQ is 1.997. The company is able to pay all its short-term debts. +1
  • The TTM is 2.099. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.997TTM2.099-0.102
TTM2.099YOY2.865-0.766
TTM2.0995Y1.412+0.687
5Y1.41210Y0.900+0.512
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.9971.887+0.110
TTM2.0991.900+0.199
YOY2.8652.104+0.761
5Y1.4122.156-0.744
10Y0.9001.840-0.940
1.3.2. Quick Ratio

Measures if Alliance Pharma plc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean)
  • A Quick Ratio of 1.48 means the company can pay off 1.48 for each 1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Alliance Pharma plc:

  • The MRQ is 1.476. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.114. The company is just able to pay all its short-term debts with the most liquid assets.
Trends
Current periodCompared to+/- 
MRQ1.476TTM1.114+0.362
TTM1.114YOY1.442-0.328
TTM1.1145Y0.718+0.396
5Y0.71810Y0.398+0.321
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4760.641+0.835
TTM1.1140.784+0.330
YOY1.4420.809+0.633
5Y0.7180.838-0.120
10Y0.3980.834-0.436

1.4. Solvency of Alliance Pharma plc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Alliance Pharma plc assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Asset Ratio of 0.44 means that Alliance Pharma plc assets are financed with 43.9% credit (debt) and the remaining percentage (100% - 43.9%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.439. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.449. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.439TTM0.449-0.010
TTM0.449YOY0.353+0.096
TTM0.4495Y0.392+0.058
5Y0.39210Y0.410-0.018
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4390.429+0.010
TTM0.4490.412+0.037
YOY0.3530.391-0.038
5Y0.3920.390+0.002
10Y0.4100.396+0.014
1.4.2. Debt to Equity Ratio

Measures if Alliance Pharma plc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A Debt to Equity ratio of 78.2% means that company has 0.78 debt for each 1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Alliance Pharma plc:

  • The MRQ is 0.782. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.816. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.782TTM0.816-0.033
TTM0.816YOY0.557+0.258
TTM0.8165Y0.652+0.164
5Y0.65210Y0.377+0.275
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7820.688+0.094
TTM0.8160.677+0.139
YOY0.5570.624-0.067
5Y0.6520.678-0.026
10Y0.3770.689-0.312

2. Market Valuation of Alliance Pharma plc

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Alliance Pharma plc.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 7,934.87 means the investor is paying 7,934.87 for every 1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Alliance Pharma plc:

  • The EOD is 4,178.936. Seems overpriced? -1
  • The MRQ is 7,934.873. Seems overpriced? -1
  • The TTM is 4,775.230. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD4,178.936MRQ7,934.873-3,755.937
MRQ7,934.873TTM4,775.230+3,159.643
TTM4,775.230YOY3,843.676+931.554
TTM4,775.2305Y2,763.643+2,011.587
5Y2,763.64310Y1,624.134+1,139.509
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD4,178.9360.297+4,178.639
MRQ7,934.8730.416+7,934.457
TTM4,775.2301.360+4,773.870
YOY3,843.6763.493+3,840.183
5Y2,763.6436.176+2,757.467
10Y1,624.1346.668+1,617.466
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Alliance Pharma plc.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Alliance Pharma plc:

  • The MRQ is -875.792. Very Bad. -2
  • The TTM is -206.454. Very Bad. -2
Trends
Current periodCompared to+/- 
MRQ-875.792TTM-206.454-669.339
TTM-206.454YOY-31.560-174.894
TTM-206.4545Y-93.789-112.665
5Y-93.78910Y-93.7890.000
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
MRQ-875.7920.003-875.795
TTM-206.4540.020-206.474
YOY-31.5600.032-31.592
5Y-93.7890.026-93.815
10Y-93.7890.029-93.818

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Alliance Pharma plc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-Specialty & Generic industry mean).
  • A PB ratio of 207.30 means the investor is paying 207.30 for each 1 in book value.

Let's take a look of the Price to Book Ratio trends of Alliance Pharma plc:

  • The EOD is 109.175. Seems overpriced? -1
  • The MRQ is 207.299. Seems overpriced? -1
  • The TTM is 193.653. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD109.175MRQ207.299-98.124
MRQ207.299TTM193.653+13.646
TTM193.653YOY145.164+48.489
TTM193.6535Y154.540+39.113
5Y154.54010Y163.636-9.096
Compared to industry (Drug Manufacturers-Specialty & Generic)
PeriodCompanyIndustry (mean)+/- 
EOD109.1751.424+107.751
MRQ207.2991.617+205.682
TTM193.6532.042+191.611
YOY145.1642.274+142.890
5Y154.5402.006+152.534
10Y163.6361.538+162.098

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Alliance Pharma plc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Per Share--0.5250.525+0%0.518+1%0.477+10%0.359+46%
Book Value Per Share Growth--0.001-0.001+140%0.002-37%0.006-77%0.008-82%
Current Ratio--1.9972.099-5%2.865-30%1.412+41%0.900+122%
Debt To Asset Ratio--0.4390.449-2%0.353+24%0.392+12%0.410+7%
Debt To Equity Ratio--0.7820.816-4%0.557+40%0.652+20%0.377+108%
Dividend Per Share--0.0050.004+33%0.003+99%0.003+70%0.003+95%
Eps---0.0010.003-125%0.004-123%0.007-111%0.004-120%
Eps Growth---9.06013.989-165%-34.606+282%29.155-131%29.155-131%
Gains Per Share--0.0070.003+99%0.005+36%0.010-28%0.011-39%
Gross Profit Margin---0.500-100%0.500-100%0.739-100%0.864-100%
Net Profit Margin----0%-0%0.119-100%0.161-100%
Operating Margin----0%-0%0.143-100%0.211-100%
Operating Ratio----0%-0%0.492-100%0.627-100%
Pb Ratio109.175-90%207.299193.653+7%145.164+43%154.540+34%163.636+27%
Pe Ratio4178.936-90%7934.8734775.230+66%3843.676+106%2763.643+187%1624.134+389%
Peg Ratio---875.792-206.454-76%-31.560-96%-93.789-89%-93.789-89%
Price Per Share57.300-90%108.800101.600+7%75.275+45%74.160+47%56.780+92%
Quick Ratio--1.4761.114+32%1.442+2%0.718+105%0.398+271%
Return On Assets---0.004-100%0.005-100%0.011-100%0.018-100%
Return On Equity---0.007-100%0.009-100%0.019-100%0.011-100%
 EOD+3 -0MRQTTM+8 -9YOY+6 -115Y+6 -1410Y+6 -14

3.2. Fundamental Score

Let's check the fundamental score of Alliance Pharma plc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-154,178.936
Price to Book Ratio (EOD)Between0-1109.175
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.476
Current Ratio (MRQ)Greater than11.997
Debt to Asset Ratio (MRQ)Less than10.439
Debt to Equity Ratio (MRQ)Less than10.782
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.050.000
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Alliance Pharma plc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5019.377
Ma 20Greater thanMa 5068.800
Ma 50Greater thanMa 10084.526
Ma 100Greater thanMa 20098.406
OpenGreater thanClose56.100
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in GBP. All numbers in thousands.

Summary
Total Assets503,488
Total Liabilities221,002
Total Stockholder Equity282,486
 As reported
Total Liabilities 221,002
Total Stockholder Equity+ 282,486
Total Assets = 503,488

Assets

Total Assets503,488
Total Current Assets81,021
Long-term Assets81,021
Total Current Assets
Cash And Cash Equivalents 29,061
Net Receivables 30,821
Inventory 21,075
Total Current Assets  (as reported)81,021
Total Current Assets  (calculated)80,957
+/- 64
Long-term Assets
Property Plant Equipment 4,826
Goodwill 31,238
Intangible Assets 382,506
Other Assets 3,897
Long-term Assets  (as reported)422,467
Long-term Assets  (calculated)422,467
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities40,577
Long-term Liabilities180,425
Total Stockholder Equity282,486
Total Current Liabilities
Accounts payable 29,930
Other Current Liabilities 10,647
Total Current Liabilities  (as reported)40,577
Total Current Liabilities  (calculated)40,577
+/-0
Long-term Liabilities
Long term Debt 116,060
Capital Lease Obligations Min Short Term Debt2,882
Other Liabilities 61,728
Long-term Liabilities Other 2,637
Long-term Liabilities  (as reported)180,425
Long-term Liabilities  (calculated)183,307
+/- 2,882
Total Stockholder Equity
Common Stock5,382
Retained Earnings 116,418
Other Stockholders Equity 160,686
Total Stockholder Equity (as reported)282,486
Total Stockholder Equity (calculated)282,486
+/-0
Other
Capital Stock5,382
Cash and Short Term Investments 29,061
Common Stock Shares Outstanding 538,226
Liabilities and Stockholders Equity 503,488
Net Debt 86,999
Net Invested Capital 398,546
Net Tangible Assets -131,258
Net Working Capital 40,444
Short Long Term Debt Total 116,060



Balance Sheet

Currency in GBP. All numbers in thousands.

 Trend2021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312019-01-312018-12-312018-09-302018-06-302018-03-312018-01-312017-12-312017-09-302017-06-302017-03-312017-01-312016-12-312016-09-302016-06-302016-03-312016-01-312015-12-312015-09-302015-06-302015-03-312015-01-312014-12-312014-09-302014-06-302014-03-312014-01-312013-12-312013-09-302013-06-302013-03-312013-01-312012-12-312012-09-302012-06-302012-03-312012-01-312011-12-312011-09-302011-06-302011-03-312011-01-312010-12-312010-09-302010-06-302010-03-312010-01-312009-12-312009-09-302009-06-302009-03-312009-01-312008-12-312008-09-302008-06-302008-03-312008-01-312007-12-312007-09-302007-06-302007-03-312007-01-312006-12-312006-09-302006-06-302006-03-312006-01-312005-09-302005-08-312005-06-302005-03-312005-02-282005-01-312004-09-302004-08-312004-06-302004-03-312004-02-292004-01-312003-09-302003-08-312003-06-302003-03-312003-01-312002-09-302002-06-302002-03-312002-01-312001-09-302001-06-302001-03-312001-01-312000-09-302000-06-302000-03-312000-01-311999-09-301999-06-301999-03-311999-01-31
> Total Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,389
0
0
26,439
0
0
25,046
0
0
34,387
0
0
35,130
0
0
0
39,933
0
48,067
0
0
48,773
0
46,406
0
0
46,770
0
48,832
0
0
48,978
0
56,800
0
0
76,715
0
77,398
0
0
78,343
0
82,286
0
0
83,854
0
100,626
0
0
105,856
0
106,991
0
0
110,242
0
107,868
0
0
121,208
0
292,194
0
0
315,000
320,737
320,737
0
318,821
318,821
336,475
336,475
0
400,253
400,253
403,609
403,609
0
407,263
407,263
0
407,637
0
400,070
0
508,853
0
513,960
0
503,488
503,4880513,9600508,8530400,0700407,6370407,263407,2630403,609403,609400,253400,2530336,475336,475318,821318,8210320,737320,737315,00000292,1940121,20800107,8680110,24200106,9910105,85600100,626083,8540082,286078,3430077,398076,7150056,800048,9780048,832046,7700046,406048,7730048,067039,93300035,1300034,3870025,0460026,4390020,3890000000000000000000
   > Total Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,573
0
0
8,303
0
0
7,280
0
0
5,985
0
0
5,997
0
0
0
5,552
0
8,308
0
0
6,496
0
6,992
0
0
7,320
0
8,651
0
0
8,759
0
11,733
0
0
15,373
0
16,223
0
0
15,157
0
15,391
0
0
17,071
0
20,172
0
0
17,931
0
16,895
0
0
16,731
0
15,670
0
0
16,872
0
27,769
0
0
42,870
49,283
49,283
0
48,526
48,526
49,127
49,127
0
53,592
53,592
58,747
58,747
0
60,333
60,333
65,037
65,037
67,899
67,899
77,239
77,239
84,772
84,772
81,021
81,021
81,02181,02184,77284,77277,23977,23967,89967,89965,03765,03760,33360,333058,74758,74753,59253,592049,12749,12748,52648,526049,28349,28342,8700027,769016,8720015,670016,7310016,895017,9310020,172017,0710015,391015,1570016,223015,3730011,73308,759008,65107,320006,99206,496008,30805,5520005,997005,985007,280008,303003,5730000000000000000000
       Cash And Cash Equivalents 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,579
0
0
3,680
0
0
1,367
0
0
268
0
0
0
0
0
232
0
0
0
0
672
0
0
106
0
4
0
0
203
0
1,104
0
0
2,302
0
1,989
0
0
1,368
0
1,079
0
0
3,161
0
4,634
0
0
1,481
0
888
0
0
430
0
1,434
0
0
499
0
3,229
0
0
3,936
7,221
7,221
0
9,006
9,006
11,184
11,184
0
14,479
14,479
10,893
10,893
0
16,468
16,468
0
17,830
0
20,524
0
28,898
0
27,390
0
29,061
29,061027,390028,898020,524017,830016,46816,468010,89310,89314,47914,479011,18411,1849,0069,00607,2217,2213,936003,2290499001,43404300088801,481004,63403,161001,07901,368001,98902,302001,1040203004010600672000023200000268001,367003,680004,5790000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
24,596
24,596
0
22,848
22,848
21,230
21,230
0
20,670
20,670
24,490
24,490
0
23,165
21,880
30,289
30,289
24,062
24,062
24,216
24,216
30,522
30,522
27,719
30,821
30,82127,71930,52230,52224,21624,21624,06224,06230,28930,28921,88023,165024,49024,49020,67020,670021,23021,23022,84822,848024,59624,59600000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
697
31,689
0
29,184
310
25,424
597
34,159
64
30,885
30,8856434,15959725,42431029,184031,68969700000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,816
0
0
18,136
0
0
17,766
0
0
28,402
0
0
29,133
0
0
0
34,381
0
39,759
0
0
42,277
0
39,414
0
0
39,450
0
40,181
0
0
40,219
0
45,067
0
0
61,342
0
61,175
0
0
63,186
0
66,895
0
0
66,783
0
80,454
0
0
87,925
0
90,096
0
0
93,511
0
92,198
0
0
104,336
0
264,425
0
0
272,130
0
271,454
0
0
270,295
0
287,348
0
0
346,661
0
344,862
0
0
346,930
0
342,600
0
332,171
0
431,614
0
429,188
0
422,467
422,4670429,1880431,6140332,1710342,6000346,93000344,8620346,66100287,3480270,29500271,4540272,13000264,4250104,3360092,198093,5110090,096087,9250080,454066,7830066,895063,1860061,175061,3420045,067040,2190040,181039,4500039,414042,2770039,759034,38100029,1330028,4020017,7660018,1360016,8160000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
182
0
0
148
0
0
201
0
0
307
0
0
299
0
0
0
256
0
297
0
0
291
0
254
0
0
205
0
161
0
0
135
0
132
0
0
580
0
888
0
0
811
0
765
0
0
663
0
564
0
0
593
0
592
0
0
524
0
396
0
0
508
0
1,013
0
0
1,182
1,806
1,806
0
2,564
2,564
3,377
3,377
0
3,907
3,907
3,341
3,341
0
4,622
4,622
4,215
11,554
3,674
12,736
4,493
15,921
5,064
19,344
4,459
4,826
4,8264,45919,3445,06415,9214,49312,7363,67411,5544,2154,6224,62203,3413,3413,9073,90703,3773,3772,5642,56401,8061,8061,182001,0130508003960524005920593005640663007650811008880580001320135001610205002540291002970256000299003070020100148001820000000000000000000
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,129
0
0
0
1,129
0
1,129
0
0
1,129
0
1,144
0
0
0
0
1,144
0
0
0
0
1,144
0
0
0
0
1,744
0
0
0
0
1,744
0
0
0
0
3,593
0
0
3,593
0
3,593
0
0
3,593
0
3,593
0
0
5,341
0
26,035
0
0
26,035
16,197
16,197
0
16,197
16,197
16,565
16,565
0
16,565
16,565
16,565
16,565
0
16,565
16,565
0
16,532
0
15,388
0
31,260
0
30,876
0
31,238
31,238030,876031,260015,388016,532016,56516,565016,56516,56516,56516,565016,56516,56516,19716,197016,19716,19726,0350026,03505,341003,59303,593003,59303,593003,59300001,74400001,74400001,14400001,14400001,14401,129001,12901,1290001,1290000000000000000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,464
1,464
0
1,650
1,650
1,483
1,483
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000001,4831,4831,6501,65001,4641,46400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
16,634
0
0
17,988
0
0
17,565
0
0
28,095
0
0
27,692
0
0
0
32,996
0
38,333
0
0
40,857
0
38,016
0
0
39,245
0
38,806
0
0
40,014
0
43,791
0
0
60,762
0
58,543
0
0
62,375
0
64,386
0
0
66,120
0
76,297
0
0
83,626
0
85,468
0
0
86,169
0
85,282
0
0
95,431
0
233,910
0
0
240,795
247,932
248,636
0
246,041
246,572
261,333
262,058
0
322,161
322,911
322,163
318,678
0
323,018
318,441
0
312,128
0
301,652
0
381,612
0
376,292
0
382,506
382,5060376,2920381,6120301,6520312,1280318,441323,0180318,678322,163322,911322,1610262,058261,333246,572246,0410248,636247,932240,79500233,910095,4310085,282086,1690085,468083,6260076,297066,1200064,386062,3750058,543060,7620043,791040,0140038,806039,2450038,016040,8570038,333032,99600027,6920028,0950017,5650017,9880016,6340000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,055
4,055
0
3,843
3,843
4,590
4,590
0
4,028
4,028
2,793
2,793
0
2,725
2,725
2,386
2,386
2,395
2,395
2,821
2,821
2,676
2,676
3,897
3,897
3,8973,8972,6762,6762,8212,8212,3952,3952,3862,3862,7252,72502,7932,7934,0284,02804,5904,5903,8433,84304,0554,05500000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20,378
0
0
24,214
0
0
23,206
0
0
27,562
0
0
27,910
0
0
0
30,182
0
37,635
0
0
39,236
0
39,740
0
0
38,116
0
40,067
0
0
38,032
0
40,170
0
0
46,038
0
41,317
0
0
36,973
0
38,158
0
0
36,442
0
48,778
0
0
48,638
0
42,323
0
0
43,198
0
37,088
0
0
48,156
0
129,752
0
0
146,984
141,474
141,474
0
131,436
131,436
133,098
133,098
0
158,829
158,829
151,410
151,410
0
149,317
149,317
0
133,457
0
127,181
0
227,895
0
233,791
0
221,002
221,0020233,7910227,8950127,1810133,4570149,317149,3170151,410151,410158,829158,8290133,098133,098131,436131,4360141,474141,474146,98400129,752048,1560037,088043,1980042,323048,6380048,778036,4420038,158036,9730041,317046,0380040,170038,0320040,067038,1160039,740039,2360037,635030,18200027,9100027,5620023,2060024,2140020,3780000000000000000000
   > Total Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,464
0
0
5,463
0
0
5,519
0
0
5,958
0
0
7,688
0
0
0
6,804
0
11,034
0
0
8,694
0
9,766
0
0
9,400
0
11,142
0
0
9,914
0
11,447
0
0
17,412
0
16,978
0
0
15,057
0
13,859
0
0
15,279
0
22,045
0
0
20,893
0
14,949
0
0
14,491
0
11,415
0
0
15,060
0
31,755
0
0
47,341
50,277
50,277
0
50,372
50,372
60,810
60,810
0
93,848
93,848
91,723
91,723
0
94,162
94,162
24,206
24,206
21,413
21,413
30,186
30,186
38,511
38,511
40,577
40,577
40,57740,57738,51138,51130,18630,18621,41321,41324,20624,20694,16294,162091,72391,72393,84893,848060,81060,81050,37250,372050,27750,27747,3410031,755015,0600011,415014,4910014,949020,8930022,045015,2790013,859015,0570016,978017,4120011,44709,9140011,14209,400009,76608,6940011,03406,8040007,688005,958005,519005,463005,4640000000000000000000
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,030
0
0
0
0
0
2,551
0
0
0
0
0
0
3,391
0
5,870
0
0
771
0
4,778
0
0
1,906
0
4,746
0
0
2,389
0
3,797
0
0
3,824
0
4,001
0
0
4,000
0
4,250
0
0
4,750
0
10,440
0
0
9,540
0
5,020
0
0
3,750
0
3,309
0
0
3,705
0
15,807
0
0
23,569
83,720
25,782
0
72,681
25,819
41,798
41,719
0
67,047
67,047
68,035
68,482
0
67,047
68,077
0
1,025
0
864
0
964
0
1,113
0
0
001,1130964086401,025068,07767,047068,48268,03567,04767,047041,71941,79825,81972,681025,78283,72023,5690015,80703,705003,30903,750005,02009,5400010,44004,750004,25004,000004,00103,824003,79702,389004,74601,906004,7780771005,87003,3910000002,551000002,0300000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83,720
83,720
0
72,681
72,681
41,798
41,798
0
67,047
67,047
68,035
68,035
0
67,047
67,047
0
0
0
0
0
0
0
0
0
0
000000000067,04767,047068,03568,03567,04767,047041,79841,79872,68172,681083,72083,72000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,655
5,655
0
5,473
5,473
6,662
6,662
0
8,664
8,664
8,978
8,978
0
7,345
7,345
6,970
6,970
7,509
7,509
11,275
11,275
10,168
10,168
8,341
29,930
29,9308,34110,16810,16811,27511,2757,5097,5096,9706,9707,3457,34508,9788,9788,6648,66406,6626,6625,4735,47305,6555,65500000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Current Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,685
6,685
0
9,669
9,669
3,865
3,865
0
7,367
7,367
2,154
2,154
0
9,803
9,803
2,803
16,211
2,932
13,040
1,853
17,947
10,579
27,230
11,495
10,647
10,64711,49527,23010,57917,9471,85313,0402,93216,2112,8039,8039,80302,1542,1547,3677,36703,8653,8659,6699,66906,6856,68500000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,914
0
0
18,751
0
0
17,687
0
0
21,604
0
0
20,222
0
0
0
23,378
0
26,601
0
0
30,542
0
29,974
0
0
28,716
0
28,925
0
0
28,118
0
28,723
0
0
28,626
0
24,339
0
0
21,916
0
24,299
0
0
21,163
0
26,733
0
0
27,745
0
27,374
0
0
28,707
0
25,673
0
0
33,096
0
97,997
0
0
99,643
0
91,197
0
0
81,064
0
72,288
0
0
64,981
0
59,687
0
0
55,155
0
109,251
0
105,768
0
197,709
0
195,280
0
180,425
180,4250195,2800197,7090105,7680109,251055,1550059,687064,9810072,288081,0640091,197099,6430097,997033,0960025,673028,7070027,374027,7450026,733021,1630024,299021,9160024,339028,6260028,723028,1180028,925028,7160029,974030,5420026,601023,37800020,2220021,6040017,6870018,7510014,9140000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
33,259
33,259
0
34,202
34,202
30,445
30,445
0
31,232
31,232
29,043
29,043
0
29,096
29,096
30,214
30,214
31,131
31,131
56,650
56,650
59,902
59,902
61,939
61,728
61,72861,93959,90259,90256,65056,65031,13131,13130,21430,21429,09629,096029,04329,04331,23231,232030,44530,44534,20234,202033,25933,25900000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
704
704
0
531
531
725
725
0
750
750
768
768
0
779
779
0
0
0
0
0
0
0
0
0
0
000000000077977907687687507500725725531531070470400000000000000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
179,263
179,263
0
187,385
187,385
203,377
203,377
0
241,424
241,424
252,199
252,199
0
257,946
257,946
0
274,180
0
272,889
0
280,958
0
280,169
0
282,486
282,4860280,1690280,9580272,8890274,1800257,946257,9460252,199252,199241,424241,4240203,377203,377187,385187,3850179,263179,26300000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Common Stock
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,726
4,726
0
4,743
4,743
4,750
4,750
0
5,150
5,150
5,182
5,182
0
5,199
5,199
5,294
5,294
5,311
5,311
5,329
5,329
5,353
5,353
5,382
5,382
5,3825,3825,3535,3535,3295,3295,3115,3115,2945,2945,1995,19905,1825,1825,1505,15004,7504,7504,7434,74304,7264,72600000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Retained Earnings Total Equity000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000-5,7940-4,9630-2,53200-3,7470000-2,0270000-1,5260000-1,4220000-1,1830000-8760000-6100000-4080000-2260000-1600000-4340000-4090000-29300000000-38000000-2650000000000000000000000
   Capital Surplus 000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Treasury Stock000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,766
4,766
0
4,657
4,657
5,017
5,017
0
6,916
6,916
7,279
7,279
0
8,085
155,634
7,337
161,336
9,938
165,464
7,281
157,926
6,514
157,478
9,358
160,686
160,6869,358157,4786,514157,9267,281165,4649,938161,3367,337155,6348,08507,2797,2796,9166,91605,0175,0174,6574,65704,7664,76600000000000000000000000000000000000000000000000000000000000000000000000000000000000000



Balance Sheet

Currency in GBP. All numbers in thousands.